GERI-BP001 Compounds, New Inhibitors of Acyl-CoA: Cholesterol Acyltransferase from Aspergillus fumigatus F37. I. Production, Isolation, and Physico-chemical and Biological Properties.

Tae‐Sook Jeong, Sung-Uk Kim, Kwang-Hee Son, Byoung‐Mog Kwon, Young‐Kook Kim, Myung‐Un Choi, Song‐Hae Bok

The Journal of Antibiotics · 1995 · 26 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

GERI-BP001 compounds, new inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT), were isolated from a culture broth of Aspergillus fumigatus F37 by acetone extraction, EtOAc extraction, SiO2 column chromatography, and reverse phase HPLC. GERI-BP001 M, A, and B inhibit ACAT activity in an enzyme assay system using rat liver microsomes by 50% at concentrations of 42, 94, and 40 microM, respectively.

References

9